Skip to main content

Table 1 Patient characteristics. (1) Long-term use group

From: A laboratory data-based evaluation of the efficacy and safety of generic pravastatin sodium for long-term use

  Long-term continued use Discontinuation (long-term)
Patients (N) 556 39
Men/women (N) 224/332 18/21
Mean age (years) 68.8 ± 10.9 73.8 ± 11.8
Mean treatment duration (weeks) 177 ± 3.61 158 ± 3.54